Students Shine at Poster Competition

Posted by Jesse McLaughlin
On April 17, 2019

One neat addition to the Spring Conference was the Student Poster Competition. We had four submissions by students from Northeastern University, University of New Hampshire and Middlesex Community College describing research they had conducted. The winners were James Sinoimeri from Northeastern (Hypoxia- Inducing Cryogels for Preclinical anticancer Drug Screening) and Nate Cunningham from UNH (Printable […]

Past President John Spohn on Winning the Chapter’s Highest Honor

Posted by John Spohn
On April 11, 2019

Yesterday I attended the inaugural Spring Conference of the Boston Area Chapter and I rate it an unqualified success. The conference on the Culture of Exceptional Project Management was indeed a perfect example thereof. Hats off to Howard Sneider and the committee that hit a home run, in their first at-bat. And the final networking […]

Chapter Member Anniversaries: March 2019

Posted by ISPE Boston
On April 5, 2019

Please congratulate the following members celebrating milestone anniversaries in March 2019. Their dedication to ISPE, the Boston Area Chapter and the industry is applauded! Over Twenty Years Saboo Aghababayan, MS, MBA, Genzyme Corp Richard Francis Caires, Jr., Shire HGT Ronald C. Case Dr. Charles L. Cooney Robert C. Davis, Process Control Solutions Edward F. […]

Welcome New Members!

Posted by ISPE Boston
On April 5, 2019

We would like to introduce the Members who joined ISPE in March 2019, welcome them to the Chapter and encourage them (and all of our members) to take advantage of the many professional development, networking and information resources available through ISPE. Fellow ISPE members are a terrific resource for help with everyday professional challenges. And […]

Ironwood to Focus on GI Diseases, Spins Off Cyclerion Therapeutics

Posted by ISPE Boston
On April 4, 2019

Ironwood Pharmaceuticals, a GI-focused healthcare company, has announced that it has completed the tax-free spin-off of its soluble guanylate cyclase (sGC) business, Cyclerion Therapeutics. Ironwood is executing on its strategy to drive growth as a GI-focused company, building upon its commercial success with Linzess and advancing its late-stage, first-in-category development candidates including IW-3718 for the […]

Ironwood Spin-Off Cyclerion Launches as Clinical-Stage Biopharm

Posted by ISPE Boston
On April 4, 2019

Cyclerion Therapeutics has announced its launch as an independent, publicly traded clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. Cyclerion will trade on the Nasdaq Global Market, commencing today, under the ticker symbol “CYCN.” “We are excited to unleash […]

Novartis Adds Anti-Inflammatory Programs with Acquisition of IFM Tre

Posted by ISPE Boston
On April 3, 2019

Pharmaceutical giant Novartis has announced the planned acquisition of Boston-based start-up IFM Tre, a subsidiary of IFM Therapeutics focused on developing anti-inflammatory medicines targeting the NLRP3 inflammasome. The acquisition will give Novartis full rights to IFM Tre’s portfolio of NLRP3 inhibitors. The NLRP3 (nucleotide-binding domain, leucine-rich repeat-containing receptor pyrin domain containing 3) pathway plays a […]

Bluebird Bio Scientists Shed Light on Cell and Gene Therapy

Posted by Alan O'Driscoll
On April 3, 2019

The Chapter’s educational program on March 21st featured a fascinating insight into the current state of gene and cell therapy. Hosted and presented by Bluebird Bio at their facility in Kendall Square, the talented team of scientists and engineers from Bluebird outlined how their process works from the preparation of the Lentivirus Vector and extraction […]

A Salute to Rob Gronkowski, 2011 Product Show Standout

Posted by ISPE Boston
On March 26, 2019

The Boston Area Chapter would like to pay tribute to Patriot’s great Rob Gronkowski after his retirement announcement on Sunday. And we’d like to remind members that we “knew him when” – way back in 2011 when he joined us for selfies and autographs at the Product Show (see photos below). Little did we guess […]

Designing Cell Therapy Facilities: Leveraging Operational Simulations

Posted by Niranjan Kulkarni, Ph.D
On March 26, 2019

Cell therapies are emerging as an important class of next-generation medicines. As many novel treatments move through development to commercialization, manufacturers are challenged to construct optimal facilities for the production of cell therapies. Modeling and simulation at the earliest design stages have many benefits. The number of cell therapy treatments in development has exploded in […]

Page 84 of 117«‹82 838485 86 ›»